NEXT GENERATION GENE THERAPEUTICS
Next Generation Gene Therapeutics is a healthcare company that engages in the research and development of gene therapy. Its unique propriety technology of "one target and two bullets" can provide effective treatment for a variety of genetic diseases that currently have few therapeutic methods in the world. NGGT was founded in March 2020 by senior scientists and entrepreneurs in the field of gene therapy. It is committed to becoming the world's leading gene therapy company with international inf... luence. The company has successful experience in the whole industry chain, concerning the early development of gene therapy products, the large-scale production of viral vectors, the construction of quality standards, international multi-center clinical research, and the application for the marketing of gene therapy products.
NEXT GENERATION GENE THERAPEUTICS
Industry:
Genetics Health Care Medical Therapeutics
Founded:
2020-03-01
Address:
Suzhou, Jiangsu, China
Country:
China
Status:
Active
Total Funding:
30 M USD
Investors List
Kington Capital
Kington Capital investment in Series A - Next Generation Gene Therapeutics
Northern Light Venture Capital
Northern Light Venture Capital investment in Series A - Next Generation Gene Therapeutics
BioVenture
BioVenture investment in Series A - Next Generation Gene Therapeutics
WeDo Capital Management
WeDo Capital Management investment in Series A - Next Generation Gene Therapeutics
More informations about "Next Generation Gene Therapeutics"
NGGT - Next Generation Gene Therapeutics
Gene therapy is pioneering a new era in medicine, offering transformative treatments for rare and chronic diseases. It has the potential to free patients from constant medication and frequent …See details»
Next Generation Gene Therapeutics - Crunchbase
Next Generation Gene Therapeutics is a healthcare company that engages in the research and development of gene therapy. Its unique propriety technology of "one target and two bullets" can provide effective treatment for a variety of …See details»
Next Generation Gene Therapeutics - Funding, Financials, …
Next Generation Gene Therapeutics is a healthcare company that engages in the research and development of gene therapy.See details»
Home - Next Generation Gene Therapy Vectors 2024 …
60+ biopharma, service provider, and academic pioneers untied to share data-driven examples of how they have improved the new wave of viral gene therapy vectors, and shared highly translatable insights into the latest disruptive non …See details»
Next Generation Gene Therapeutics - Products, Competitors, …
Nov 11, 2024 · Next Generation Gene Therapeutics is a gene therapy drug research and development company that focuses on the early development of gene therapy projects, …See details»
Gene Therapy: The Next-Generation Therapeutics and Their …
Given recent advancements, gene therapy shows great promise to emerge as a next-generation therapeutic for many of the neurodevelopmental and neurodegenerative conditions. Keywords: …See details»
Evolution of Next Generation Therapeutics: Past, Present, and …
With increasing emphasis on precision approaches to therapeutics, product development has shifted focus to a genome‐guided approach to develop novel therapeutics. This Commentary …See details»
Preparing to deliver next-generation therapeutics
Jan 20, 2022 · Mayo Clinic is among the academic medical centers on the cusp of biomanufacturing next-generation cell and gene therapies that offer hope of new cures for rare …See details»
Next-generation therapeutics thrust into the spotlight
Sep 1, 2021 · COVID-19 has accelerated development and awareness of next-generation therapeutics, including mRNA vaccines, boosting the field’s dealmaking and investment activities. The past 12 months have...See details»
Voyager Enters into License for Next-Generation Capsid, Bringing ...
LEXINGTON, Mass., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, …See details»
Engineering the next generation of cell-based therapeutics
May 30, 2022 · In this Review, we discuss how progress towards new and more effective cell therapies that overcome these challenges will require development of abilities to complement, …See details»
Next-generation therapeutics sustain momentum - Nature
Jun 9, 2020 · The next-generation therapeutics space has continued to progress on several fronts in the past 12 months, but this could be set to change as the industry copes with the …See details»
Next-generation therapeutics for rare genetic disorders
Feb 9, 2024 · Advanced technologies that use CRISPR-Cas 9, antisense oligonucleotides, siRNA, miRNA, and aptamers are promising tools that have achieved successful breakthroughs in the …See details»
The next generation of gene therapy for rare diseases forges …
Dec 14, 2020 · Generation’s lead gene therapy candidates are designed to treat rare blood disorders hemophilia A and phenylketonuria (PKU), and they’re still in preclinical development.See details»
Engineering the next generation of cell-based therapeutics
Here, Veiseh and colleagues overview progress in the development of cell-based therapeutics and discuss how biological engineering approaches — including genome editing, synthetic …See details»
Next-generation therapeutics: cell and gene therapy gathers pace
Aug 2, 2019 · Evaluate’s analysis reveals >5,000 active research and development programs for cell-based and gene-based medicine, and while there is substantial ongoing work in oncology, …See details»
Next-generation therapeutics thrust into the spotlight - Nature
Gene therapy is forecast to be the largest next-generation segment in 2026 at $20 billion, led by Novartis’s Zolgensma (onasemnogene abeparvovec) for spinal muscular atrophy, highlighted …See details»
Taking gene therapy to the next level - Nature
Shape Therapeutics is developing next-generation gene-therapy technologies that harness the power of artificial intelligence and RNA editing to repair disease-causing mutations.See details»
Next-generation therapeutics sustain momentum - Nature
The next-generation therapeutics space has continued to progress on several fronts in the past 12 months, but this could be set to change as the industry copes with the COVID-19 crisis. 18,000See details»
Roche inks $1.5B Poseida buyout to land off-the-shelf CAR-Ts
2 days ago · Roche has struck a $1.5 billion deal to buy Poseida Therapeutics. The takeover will establish off-the-shelf cell therapies, which Roche has said can democratize CAR-Ts, as a …See details»